کارخانجات‌داروپخش‌

دارو | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 9,690 2.43
Close Price: 9,400

Financial Ratios

2026/06/17
Fiscal Year 2026/03/2012 Month
2025/05/28
Fiscal Year 2025/03/2012 Month
2024/06/02
Fiscal Year 2024/03/1912 Month

Net Profit to Sales

31.0714.598.98

Gross Profit to Sales

42.2118.8213.95

Operating Margin

48.6830.3426.27

Gross Profit to Sales

51.7235.4728.96

Net Profit to Gross Profit

60.0841.1330.99

Return on Assets (ROA)

19.825.647.13

Return on Capital (%)

51.81208.69124.53

Return on Equity (ROE)

32.879.4246.22

Working Capital Return

78.2960.1866.8

Fixed Asset Return

52.2610.5787.1

Loan Benefit Assessment

1.661.676.48

Current Ratio

1.691.251.13

Quick Ratio

1.340.890.87

Liquidity Ratio

0.010.020.02

Net Working Capital

34,278,6249,016,1514,846,621

Current Assets Ratio

0.620.470.92

Inventory Turnover

133.46170.56136

Receivables Collection Period

253.94282.21311.04

Inventory to Working Capital

0.511.441.95

Working Capital Turnover

2.524.137.44

Fixed Asset Turnover

1.680.729.7

Total Asset Turnover

0.640.390.79

Debt Ratio

0.40.40.85

Debt to Equity

0.660.675.48

Long-Term Debt to Equity

0.050.050.23

Current Debt to Equity

0.610.625.25

Equity Ratio

60.2859.9215.43

Debt Coverage Ratio

12.6918.582.32